
TY  - JOUR
TI  - Mini Orals
JO  - Nephrology
JA  - Nephrology
VL  - 22
IS  - S3
SN  - 1320-5358
UR  - https://doi.org/10.1111/nep.13104
DO  - doi:10.1111/nep.13104
SP  - 18
EP  - 50
PY  - 2017
ER  - 

TY  - JOUR
TI  - Oral Session
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 23
IS  - S2
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.13091
DO  - doi:10.1111/ene.13091
SP  - 21
EP  - 110
PY  - 2016
ER  - 

TY  - JOUR
TI  - Posters
JO  - Glia
JA  - Glia
VL  - 59
IS  - S1
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.21210
DO  - doi:10.1002/glia.21210
SP  - S42
EP  - S154
KW  - neurodegeneration
KW  - immune response
KW  - signal transduction
PY  - 2011
ER  - 

TY  - JOUR
TI  - Invited Speakers Abstracts
JO  - Respirology
VL  - 13
IS  - s5
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2008.01427.x
DO  - doi:10.1111/j.1440-1843.2008.01427.x
SP  - A77
EP  - A100
PY  - 2008
ER  - 

AU  - Fuller, Stephanie J.
AU  - Sohrabi, Hamid R.
AU  - Goozee, Kathryn G.
AU  - Sankaranarayanan, Anoop
AU  - Martins, Ralph N.
C7  - pp. 9-42
TI  - Alzheimer's Disease and Other Neurodegenerative Diseases
SN  - 9781119356783
UR  - https://doi.org/10.1002/9781119356752.ch2
DO  - doi:10.1002/9781119356752.ch2
SP  - 9-42
KW  - Alzheimer's disease
KW  - cardiovascular disease
KW  - disease pathology
KW  - lifestyle changes
KW  - neurodegenerative conditions
KW  - Parkinson's disease
KW  - type 2 diabetes
KW  - vascular dementia
PY  - 2008
AB  - Summary Neurodegenerative diseases are a heterogeneous group of disorders or conditions characterised by the progressive degeneration of the structure and function of the central nervous system or the peripheral nervous system. Some are considered to be caused by protein misfolding, some involve disruptions to intracellular processes such as mitochondrial function or protein degradation pathways, and some are genetic in origin. Whatever the original cause of the disease, the greatest risk factor for most of these diseases is increasing age. This book is mostly focused on Alzheimer's disease (AD), yet in this chapter we describe Alzheimer's as well as other major neurodegenerative conditions to demonstrate both similarities and differences.
ER  - 

TY  - JOUR
AU  - Derkus, Burak
AU  - Emregul, Kaan C.
AU  - Emregul, Emel
TI  - A new approach in stem cell research—Exosomes: Their mechanism of action via cellular pathways
JO  - Cell Biology International
JA  - Cell Biol Int
VL  - 41
IS  - 5
SN  - 9781119356783
UR  - https://doi.org/10.1002/cbin.10742
DO  - doi:10.1002/cbin.10742
SP  - 466
EP  - 475
KW  - cell biology
KW  - differentiation
KW  - exosome
KW  - miRNA
KW  - stem cell
PY  - 2017
AB  - Abstract Exosomes are nano-sized vesicles surrounded by a lipid membrane, which tend to be secreted toward extra-cellular environments. Despite being defined as vesicles involved in excretion of molecular wastes by Rose Johnstone in the 1970s, further studies revealed them to be effective in various biological processes such as cancer development, regulation of the immune system, intercellular communication, stem cell biology, and tissue/organ regeneration. Although many studies dealing with the role of exosomes in stem cell differentiation and the use of exosomes isolated from stem cells for the treatment of several diseases have been published, the involved mechanisms remain largely unknown. Further understanding of these mechanisms, which include the involved cellular pathways, may improve the use of exosomes in diagnostic and treatment methods, especially for those involving stem cells. Here, we describe some recent data describing the action mechanism of stem cell-derived exosomes focusing on the implicated cellular pathways, hoping to provide novel information that will be useful for cell biology scientists working in this field.
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Reproduction in Domestic Animals
JA  - Reprod Dom Anim
VL  - 53
IS  - S2
SN  - 9781119356783
UR  - https://doi.org/10.1111/rda.13272
DO  - doi:10.1111/rda.13272
SP  - 100
EP  - 215
PY  - 2018
ER  - 

TY  - JOUR
AU  - Kissil, Joseph L.
AU  - Blakeley, Jaishri O.
AU  - Ferner, Rosalie E.
AU  - Huson, Susan M.
AU  - Kalamarides, Michel
AU  - Mautner, Victor-Felix
AU  - McCormick, Frank
AU  - Morrison, Helen
AU  - Packer, Roger
AU  - Ramesh, Vijaya
AU  - Ratner, Nancy
AU  - Rauen, Katherine A.
AU  - Stevenson, David A.
AU  - Hunter-Schaedle, Kim
AU  - North, Kathryn
TI  - What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: New Frontiers
JO  - American Journal of Medical Genetics Part A
JA  - Am. J. Med. Genet.
VL  - 152A
IS  - 2
SN  - 9781119356783
UR  - https://doi.org/10.1002/ajmg.a.33189
DO  - doi:10.1002/ajmg.a.33189
SP  - 269
EP  - 283
KW  - neurofibromatosis type 1
KW  - neurofibromatosis type 2
KW  - NF1
KW  - NF2
KW  - schwannomatosis
KW  - tumor suppressor
KW  - Ras/MAPK
KW  - learning disabilities
KW  - bone dysplasia
PY  - 2010
AB  - Abstract The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children's Tumor Foundation for over 20 years. The 2009 NF Conference was held in Portland, Oregon from June 13 to June 16, 2009 and co-chaired by Kathryn North from the University of Sydney and The Children's Hospital at Westmead, Sydney, Australia; and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts presented as posters; and three Keynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, and more recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly the NF Conference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflected in the highlights from the 2009 NF Conference presented here. ? 2010 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
AU  - Bull, Sarah
AU  - Burnett, Karin
AU  - Vassaux, Kate
AU  - Ashdown, Lini
AU  - Brown, Terry
AU  - Rushton, Lesley
C7  - 572E
TI  - Extensive literature search and provision of summaries of studies related to the oral toxicity of perfluoroalkylated substances (PFASs), their precursors and potential replacements in experimental animals and humans. Area 1: Data on toxicokinetics (absorption, distribution, metabolism, excretion) in in vitro studies, experimental animals and humans. Area 2: Data on toxicity in experimental animals. Area 3: Data on observations in humans
JO  - EFSA Supporting Publications
JA  - EFSA Supporting Publications
VL  - 11
IS  - 4
SN  - 9781119356783
UR  - https://doi.org/10.2903/sp.efsa.2014.EN-572
DO  - doi:10.2903/sp.efsa.2014.EN-572
SP  - 572E
KW  - perfluoroalkylated substances
KW  - toxicity
KW  - in vitro
KW  - experimental animals
KW  - humans
KW  - literature search
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session 1
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 9781119356783
UR  - https://doi.org/10.1002/ejhf.93_4
DO  - doi:10.1002/ejhf.93_4
SP  - 19
EP  - 98
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Exhibition Abstracts
JO  - HIV Medicine
VL  - 10
IS  - s2
SN  - 9781119356783
UR  - https://doi.org/10.1111/j.1468-1293.2009.00792.x
DO  - doi:10.1111/j.1468-1293.2009.00792.x
SP  - 45
EP  - 221
PY  - 2009
ER  - 

TY  - JOUR
TI  - Keyword index
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 125
IS  - s1
SN  - 9781119356783
UR  - https://doi.org/10.1111/jnc.12233
DO  - doi:10.1111/jnc.12233
SP  - 295
EP  - 307
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts of the IBANGS Genes, Brain and Behavior Meeting May 16-19, 2012 Boulder, Colorado, USA
JO  - Genes, Brain and Behavior
VL  - 11
IS  - 4
SN  - 9781119356783
UR  - https://doi.org/10.1111/j.1601-183X.2012.00809.x
DO  - doi:10.1111/j.1601-183X.2012.00809.x
SP  - 461
EP  - 499
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Transplant International
JA  - Transpl Int
VL  - 30
IS  - S1
SN  - 9781119356783
UR  - https://doi.org/10.1111/tri.12885
DO  - doi:10.1111/tri.12885
SP  - 5
EP  - 25
PY  - 2017
ER  - 

TY  - JOUR
TI  - Scientific Program
JO  - American Journal of Transplantation
VL  - 8
IS  - s2
SN  - 9781119356783
UR  - https://doi.org/10.1111/j.1600-6143.2008.02253.x
DO  - doi:10.1111/j.1600-6143.2008.02253.x
SP  - 57
EP  - 176
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster Session 2
JO  - International Journal of Gynecological Cancer
VL  - 16
IS  - s3
SN  - 9781119356783
UR  - https://doi.org/10.1111/j.1525-1438.2006.00739.x
DO  - doi:10.1111/j.1525-1438.2006.00739.x
SP  - 695
EP  - 763
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - The FEBS Journal
VL  - 274
IS  - s1
SN  - 9781119356783
UR  - https://doi.org/10.1111/j.0014-2956.2007.05861_3.x
DO  - doi:10.1111/j.0014-2956.2007.05861_3.x
SP  - 133
EP  - 220
PY  - 2007
ER  - 

TY  - JOUR
TI  - Preliminary Program and Abstracts for the Eighth American Hepato Pancreato Biliary Congress Annual Scientific Session and Postgraduate Course March 27–30, 2008 Marriott's Harbor Beach Resort & Spa Ft. Lauderdale, Florida
JO  - HPB
VL  - 10
IS  - s2
SN  - 9781119356783
UR  - https://doi.org/10.1080/13651820801953510
DO  - doi:10.1080/13651820801953510
SP  - 1
EP  - 27
PY  - 2008
ER  - 

TY  - JOUR
TI  - Wednesday 31 August 2011
JO  - Journal of Neurochemistry
VL  - 118
IS  - s1
SN  - 9781119356783
UR  - https://doi.org/10.1111/j.1471-4159.2011.07326.x
DO  - doi:10.1111/j.1471-4159.2011.07326.x
SP  - 165
EP  - 244
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts 624–854
JO  - Hepatology
JA  - Hepatology
VL  - 50
IS  - S4
SN  - 9781119356783
UR  - https://doi.org/10.1002/hep.23303
DO  - doi:10.1002/hep.23303
SP  - 600A
EP  - 705A
PY  - 2009
ER  - 
